The Time Dependence of Antithrombin Initiation in Patients With Non-ST-segment Elevation Acute Coronary Syndromes: Subgroup Analysis From the ACUITY Trial

In this study of patients with non-ST-segment elevation acute coronary syndromes who were undergoing an early invasive management strategy, we were unable to demonstrate an association between adverse ischemic outcomes with the timing of antithrombin administration. However, there was an increase in bleeding outcomes as time to antithrombin administration increased.